• Therapy
  • Khalil A, Muttukrishna S, Harrington K, Jauniaux E, 2008 Effect of Antihypertensive Therapy with Alpha Methyldopa on Levels of Angiogenic Factors in Pregnancies with Hypertensive Disorders. (wikipedia.org)
  • therapeutic
  • This report provides information on the therapeutic development based on the Vascular Endothelial Growth Factor D (VEGF-D) Inhibitors dealing with mechanism of action, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. (sbwire.com)
  • levels
  • The knowledge gap about VEGF-B expression and how its levels are altered in diabetic eyes were the focus of this investigation that was addressed by comparing and correlating vitreous VEGF-B between diabetic and non-diabetic patients. (mdpi.com)
  • VEGF-B levels were measured by enzyme-linked immunosorbent assay in vitreous samples ( n = 33) from diabetic ( n = 25) and non-diabetic ( n = 8) patients. (mdpi.com)
  • mean
  • The mean VEGF CSF at presentation, 1 week, and 2 weeks after admission was 568 pg/mL, 751 pg/mL, and 1031 pg/mL, respectively. (ajtmh.org)
  • Optical coherence tomography from diabetic patients was evaluated for central retinal thickness (CRT) and macular volume (MV). Mean vitreous VEGF-B concentration was higher in diabetic (18.82 ± 1.44 pg/mL ) vs. non-diabetic patients (17.90 ± 0.32 pg/mL) ( p = 0.006), and in proliferative diabetic retinopathy (PDR) (19.03 ± 1.52 pg/mL) vs. non-PDR (NPDR) patients (18.18 ±0.96 pg/mL) ( p = 0.025). (mdpi.com)
  • presentation
  • VEGF CSF was detected in 8 (90%) of 9 eosinophilic meningitis patients (range, 45-2190 pg/mL) at presentation. (ajtmh.org)
  • delivery
  • Blood pressure augmentation and maternal circulating concentrations of angiogenic factors at delivery in preeclamptic and uncomplicated pregnancies. (wikipedia.org)